Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Docetaxel Injection Concentrate 120 mg
  Indications :
 

Breast cancer

Prostate cancer

Non-small cell lung cancer

Gastric Adenocareinoma

   
  Dosage :
  Breast Cancer :
60-100 mg/m2 administered intravenously over 1 hour every 3 weeks.

Non-Small Cell Lung Cancer :
75 mg/m2 administered intravenously over 1 hour every 3 weeks.

Prostate cancer : 75 mg/m2 every 3 weeks as a single dose Hormone-refractory metastatic prostate given the concurrent use of prednisolone, the recommended premedication regimen is oral dexamethasone 8mg at 12 hours, 3 hours and 1 hour before the docetaxel infusion. intravenous infusion before Biogem administration.

Gastric Adenocarcinoma :
75 mg/m2 as a 1 hour intravenous infusion.

Followed by :
cisplatin 75 mg/m2, as a 1 to 3 hour intravenous infusion (both on day 1 only), & fluorouracil 750 mg/m2 per day given as a 24-hour continuous intravenous infusion for 5 days.

Dosage Adjustment :

Renal Impairment : Not Required.

Hepatic Impairment : Required.
   
  Packing : 5 Vials of 120 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.